X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 63 filers reported holding X4 PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,345 | -52.5% | 11,326 | -15.5% | 0.00% | – |
| Q2 2023 | $25,996 | +116.6% | 13,400 | +841.7% | 0.00% | – |
| Q1 2021 | $12,000 | +33.3% | 1,423 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | -10.0% | 1,423 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -41.2% | 1,423 | -23.5% | 0.00% | – |
| Q2 2020 | $17,000 | -19.0% | 1,861 | -21.5% | 0.00% | – |
| Q1 2020 | $21,000 | -22.2% | 2,372 | -4.8% | 0.00% | – |
| Q4 2019 | $27,000 | +8.0% | 2,492 | +25.8% | 0.00% | – |
| Q3 2019 | $25,000 | +47.1% | 1,981 | +70.0% | 0.00% | – |
| Q2 2019 | $17,000 | +750.0% | 1,165 | +782.6% | 0.00% | – |
| Q1 2019 | $2,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |